LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Richard Grant Joins Spinal Simplicity
People In The News

Richard Grant Joins Spinal Simplicity

July 28, 2017 2 min read Premium comments

Advertisement

Richard Grant Joins Spinal Simplicity
Richard Grant
#spinalsimplicity#richardgrant

Richard Grant, former president and chief executive officer of TheraCell, Inc., has joined Spinal Simplicity, LLC as an Advisor and member of the company’s Board of Managers. Spinal Simplicity is headquartered in Overland Park, Kansas.

As the company wrote in its July 19, 2017 news release, “Richard Grant brings a wealth of experience to Spinal Simplicity as an accomplished medical device executive with over 30 years in the spinal and orthopedic medical industries. As President, CEO and Co-Founder of Breakaway Imaging, LLC, Grant successfully developed new imaging technology (the O-Arm), incorporating 2-D (fluoroscopy) and 3-D (CT) imaging, in a mobile platform optimized for orthopedic and spinal surgeries. Grant orchestrated the sale of Breakaway Imaging, LLC to Medtronic, Inc. in June 2007.”

“Grant also has extensive experience with early-stage medical device companies as evidenced by his work as President and CEO of TheraCell, Inc., in Northridge, CA, specializing in stem cell harvesting and processing for orthopedic applications, and, as President of Bonovo Orthopedics in Phoenix, AZ, a US-based company that manufactures and distributes spine and orthopedic instrumentation and implants in China.”

“Grant currently serves on the Board of Directors of two medical device companies, an orthopedic bracing company and an ortho-biologic company, while also serving as the Chairman of the Board of a company specializing in computer-assisted total knee solutions. Notably, Grant also served on the Board of Directors of Excelsius Surgical (sold to Globus Medical), Nocimed (partnering with NuVasive), and Angstrom Medica (sold to Pioneer Surgical).”

Todd Moseley, CEO of Spinal Simplicity, applauded Grant’s significant industry experience stating, “Rich is an admired executive in the spine and orthopedic medical device world. Spinal Simplicity will benefit mightily from Rich’s knowledge and experience navigating early-stage companies from initial innovation to becoming market leaders. Our Company will have the unique advantage of calling upon Rich’s experience as we bring the Minuteman G3-R to the minimally-invasive spine market to enhance posterior supplemental fixation and fusion, as well as to introduce our ground-breaking Wolff’s Law™ plating technology to the spinal and orthopedic extremities market.”

Grant agreed that this is an extraordinary time for Spinal Simplicity, “As the Company experiences the positive responses being lauded by physicians to its revolutionary technology, it becomes more and more evident that the spinal and orthopedic markets are ready for innovative medical devices. The time is ripe to get the word out about the innovation being unveiled by Spinal Simplicity.”

Grant commented to OTW, “I plan to use my experience and contacts to gain visibility for Spinal Simplicity to the industry. Also, in the current stage of the company, assist with early commercialization and work with the team to grow both organically as well as explore strategic partnering.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy